Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

OBJECTIVES This study assessed the incremental prognostic implications of normal and equivocal exercise technetium-99m (Tc-99m) sestamibi single-photon emission computed tomography (SPECT) and sought to determine its incremental prognostic value, impact on patient management and cost implications. BACKGROUND The prognostic implications of Tc-99m sestamibi SPECT are not well defined, and risk stratification using this test has not been explored. METHODS We studied 1,702 patients referred for exercise Tc-99m sestamibi SPECT who were followed up for a mean (+/- SD) of 20 +/- 5 months. Patients with previous percutaneous transluminal coronary angioplasty or coronary artery bypass surgery were excluded. The SPECT studies were assessed using semiquantitative visual analysis. Cardiac death and myocardial infarction were considered "hard" events, and coronary angioplasty and bypass surgery > 60 days after testing were considered "soft" events. RESULTS Of the 1,702 patients studied, 1,131 had normal or equivocal scan results. A total of 10 events occurred in this group (1 cardiac death and 1 myocardial infarction [0.2% hard events]; 4 coronary angioplasty and 4 bypass surgery procedures [0.7% soft events]). The rates of hard events and referral to catheterization after SPECT were similarly low in patients with a low (< 0.15), intermediate (0.15 to 0.85) and high (> 0.85) post-exercise treadmill test (ETT) likelihood of coronary artery disease. With respect to scan type, patients with normal, probably normal or equivocal scan results had similarly low hard event rates. In the 571 patients with abnormal scan results, there were 43 hard events (7.5%) and 42 soft events (7.4%) (p < 0.001 vs. 1,131 patients with normal scan results for both). When the complete spectrum of scan responses was considered, SPECT provided incremental prognostic value in all patient subgroups analyzed. However, the nuclear scan was cost-effective only in patients with interpretable exercise ECG responses and an intermediate to high post-ETT likelihood of coronary artery disease and in those with uninterpretable exercise ECG responses and an intermediate to high pre-ETT likelihood of coronary artery disease. CONCLUSIONS Normal or equivocal exercise Tc-99m sestamibi study results are associated with a benign prognosis, even in patients with a high likelihood of coronary artery disease. Although incremental prognostic value is added by nuclear testing in all patient subgroups, a testing strategy incorporating nuclear testing proved to be cost-effective only in the groups with an intermediate to high likelihood of coronary artery disease before scanning.

[1]  F. Wackers,et al.  Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. , 1985, Journal of the American College of Cardiology.

[2]  G. Diamond,et al.  Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. , 1983, Journal of the American College of Cardiology.

[3]  K. Narahara,et al.  Comparison of thallium-201 and technetium-99m hexakis 2-methoxyisobutyl isonitrile single-photon emission computed tomography for estimating the extent of myocardial ischemia and infarction in coronary artery disease. , 1990, The American journal of cardiology.

[4]  W. P. Dixon,et al.  BMPD statistical software manual , 1988 .

[5]  D. Berman,et al.  Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  D. Berman,et al.  Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. , 1987, The American journal of cardiology.

[7]  D. Berman,et al.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. , 1993, Journal of the American College of Cardiology.

[8]  G. Diamond,et al.  Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. , 1990, Annals of internal medicine.

[9]  A. Quyyumi,et al.  Myocardial Viability in Patients With Chronic Coronary Artery Disease: Comparison of 99mTc‐Sestamibi With Thallium Reinjection and [18F]Fluorodeoxyglucose , 1994, Circulation.

[10]  G Germano,et al.  Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  B. Chaitman,et al.  Exercise Technetium‐99m Sestamibi Tomography for Cardiac Risk Stratification of Patients With Stable Chest Pain , 1994, Circulation.

[12]  A. León,et al.  Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs. , 1992, Journal of the American College of Cardiology.

[13]  D. Berman,et al.  Development and prospective application of quantitative 2-day stress-rest Tc-99m methoxy isobutyl isonitrile SPECT for the diagnosis of coronary artery disease. , 1990, American heart journal.

[14]  M. Rowen,et al.  Prognostic value of normal technetium-99m-sestamibi cardiac imaging. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  E G DePuey,et al.  Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. , 1990, The American journal of cardiology.

[16]  D. Berman,et al.  Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. , 1986, Journal of the American College of Cardiology.

[17]  P. Longère,et al.  Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. , 1994, Journal of the American College of Cardiology.

[18]  R. Okada,et al.  Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. , 1983, Journal of the American College of Cardiology.

[19]  M. Rowen,et al.  Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. , 1993, The American journal of cardiology.

[20]  K. Brown Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. , 1991, Circulation.

[21]  H Kiat,et al.  Technetium 99m sestamibi in the assessment of chronic coronary artery disease. , 1991, Seminars in nuclear medicine.

[22]  D. Berman,et al.  Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. , 1990, The American journal of cardiology.

[23]  W. Wijns,et al.  Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. , 1985, Circulation.

[24]  R. Taillefer,et al.  Myocardial technetium 99m-labeled sestamibi single-photon emission computed tomographic imaging in the detection of coronary artery disease: Comparison between early (15 minutes) and delayed (60 minutes) imaging , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[25]  D. Berman,et al.  The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime. , 1991, Circulation.

[26]  M. Ghods,et al.  Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. , 1994, The American journal of cardiology.

[27]  D. Berman,et al.  Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  K. Bailey,et al.  Exercise Tomographic Thallium-201 Imaging in Patients with Severe Coronary Artery Disease and Normal Electrocardiograms , 1994, Annals of Internal Medicine.

[29]  S. Kaul,et al.  Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.

[30]  E. Picano,et al.  Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. , 1993, The American journal of cardiology.

[31]  J. Ritchie,et al.  Myocardial imaging with 201thallium: an analysis of clinical usefulness based on Bayes' theorem. , 1978, Seminars in nuclear medicine.

[32]  S. Marsch,et al.  Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. , 1989, The American journal of cardiology.

[33]  G. Beller,et al.  Prognosis with chest pain and normal thallium-201 exercise scintigrams. , 1985, The American journal of cardiology.

[34]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .